IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.
复制标题
DOI:
10.1136/gutjnl-2013-305671
复制
发表时间:
2014-11
期刊:
影响因子:
24.5
通讯作者:
Strober W
中科院分区:
文献类型:
--
作者:
Fuss IJ;Joshi B;Yang Z;Degheidy H;Fichtner-Feigl S;de Souza H;Rieder F;Scaldaferri F;Schirbel A;Scarpa M;West G;Yi C;Xu L;Leland P;Yao M;Mannon P;Puri RK;Fiocchi C;Strober W
Previous studies have shown that ulcerative colitis (UC) is associated with the presence of lamina propria non-invariant (Type II) NKT cells producing IL-13 and mediating epithelial cell cytotoxicity. Here we sought to define the antigen(s) stimulating the NKT cells and to quantitate these cells in the UC lamina propria. Detection of Type II NKT cells in UC lamina propria mononuclear cells (LPMCs) with lysosulfatide loaded tetramer and quantum dot-based flow cytometry and staining. Culture of UC LPMCs with lyso-sulfatide glycolipid to determine sulfatide induction of epithelial cell cytotoxicity, IL-13 production and IL-13Rα2 expression. Blinded quantum dot-based phenotypic analysis to assess UC LPMC expression of IL-13Rα2, CD161 and IL-13. Approximately 36% of UC LPMC were lyso-sulfatide tetramer positive whereas few if any control LPMC were positive. When tested, the positive cells were also CD3 and IL-13Rα2 positive. Culture of UC LPMC with lyso-sulfatide glycolipid showed that sulfatide stimulates UC LPMC production of IL-13 and induces UC CD161+ LPMC-mediated cytotoxicity of activated epithelial cells; in addition, lyso-sulfatide induces enhanced expression of IL-13Rα2. Finally, blinded phenotypic analysis of UC LP MC using multi-color quantum dot staining technology showed that approximately 60% of the LPMC bear both IL-13Rα2 and CD161 and most of these cells also produce IL-13. These studies show that UC lamina propria is replete with Type II NKT cells responsive to lyso-sulfatide glycolipid and bearing IL-13Rα2. Since lyso-sulfatide is a self-antigen these data suggest that an autoimmune response is involved in UC pathogenesis.